Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Feb 8, 03:46 AM 2012 
  NYSE  8069.71    NASDAQ  2904.08  
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for SLXP and AUXL...
    
  Salix Pharmaceuticals Ltd.  and    Auxilium Pharmaceuticals Inc.
        
    
Diversification
Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Auxilium Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
0.38
 Parameters
Time Period1 Month [change]
DirectionPositive AUXL Moved Up vs SLXP
StrengthVery Weak
Accuracy86.96%
ValuesDaily Returns
    
    

       

Salix Pharmaceuticals Ltd.

    
    
48.43
  
Salix Quote
Intraday
 
Salix Intraday Quote
One Month
 0.00   No Change   0.00%  
SLXP Macroaxis: United States NASDAQ
Salix Pharmaceuticals Ltd.
P/E37.25LowNot Applicable
P/B Ratio5.96Market Cap2.864B
SectorHealthcareLast Close48.43
Short Ratio7.80Last Traded2/7/2012
Year High50.28Change (%)Not Applicable
EBITDA142.7MYear Low25.64
Book Value8.127EPS1.30
PEG Ratio0.94Employees390
Target Price54.27Current EPS1.30
This Year EPS2.53Next Year EPS2.78
Current PE37.25This Year PE19.14
Next Year PE17.42DividendNot Applicable
  

Auxilium Pharmaceuticals Inc.

    
    
20.06
  
Auxilium Quote
Intraday
 
Auxilium Intraday Quote
One Month
 0.00   No Change   0.00%  
AUXL Macroaxis: United States NASDAQ
Auxilium Pharmaceuticals Inc.
P/B Ratio10.77Market Cap961.9M
SectorHealthcareLast Close20.06
Short Ratio7.80Last Traded2/7/2012
Year High25.10Change (%)Not Applicable
EBITDA-30.1MYear Low13.59
Book Value1.862EPS-0.783
Employees540HighNot Applicable
Target Price21.29Current EPS-0.783
This Year EPS-0.60Next Year EPS-0.38